AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Fasenra - Drug Insights, 2019-2021 - ResearchAndMarkets.com

December 30, 2019 GMT

DUBLIN--(BUSINESS WIRE)--Dec 30, 2019--

The “Fasenra - Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering.

Fasenra - Drug Insight, 2019 report provides comprehensive information of the drug, Fasenra. It includes drugs overview, Fasenra mechanism of action, clinical trials, regulatory milestones, deals & Fasenra’s partnerships. It further provides Fasenra’s patents (US & EU) and its API manufacturers details in the United States, Europe, China and India.

It also features the historical and forecasted Fasenra sales till 2021. The report also throws light on Fasenra market competition and emerging therapies in the same space as Fasenra. Fasenra SWOT analysis is also featured.

Scope of the Report

Reasons to Buy

Key Topics Covered

1. Report Introduction

2. Fasenra - Overview

3. Global API Manufacturers

4. Product Details

5. Fasenra Global Sales Assessment

6. Fasenra Patent Details

7. Fasenra Market Competition

8. Fasenra Emerging Therapies

8.1. Drug name: Company name

9. Fasenra SWOT Analysis

List of Tables

Table 1: Fasenra, Description

Table 2: API Manufacturers Region wise

Table 3: API Manufacturers for United States

Table 4: API Manufacturers for Europe

Table 5: API Manufacturers for China

Table 6: API Manufacturers for India

Table 7: Fasenra Product Details, United States

Table 8: Fasenra Product Details, Europe

Table 9: Fasenra, Historical Global Sales till 2017 (in million USD)

Table 10: Fasenra, Forecasted Global Sales from 2019-2021 (in million USD)

Table 11: Patent Details: Fasenra

Table 12: Fasenra Major Competitors

Table 13: Emerging Therapies

List of Figures

Figure 1: Fasenra

Figure 2: Fasenra, Historical Global Sales till 2017 (in million USD)

Figure 3: Fasenra, Forecasted Global Sales from 2019-2021 (in million USD)

Figure 4: Patent Details: Fasenra

Figure 5: API Manufacturers Region wise

For more information about this report visit https://www.researchandmarkets.com/r/amg2de

View source version on businesswire.com:https://www.businesswire.com/news/home/20191230005205/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 12/30/2019 09:41 AM/DISC: 12/30/2019 09:41 AM

http://www.businesswire.com/news/home/20191230005205/en